Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melina E Marmarelis

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Current Oncology Reports|May 10, 2018
Combination Immunotherapy in Non-small Cell Lung CancerMelina E Marmarelis, Charu Aggarwal
JAMA Network Open|June 30, 2025
Immunotherapy for Resectable Non-Small Cell Lung Cancer-Not If, But WhenLauren Reed-Guy, Melina E Marmarelis
Clinical Lung Cancer|June 8, 2020
Treatment of Patients With Non-Small-Cell Lung Cancer Harboring Rare Oncogenic MutationsMelina E Marmarelis, Corey J Langer
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2020
Next-generation Sequencing of Cerebrospinal Fluid: How Can a Liquid be Like a Solid?Melina E Marmarelis, Joshua M Bauml
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 26, 2023
Adjuvant Atezolizumab Should Be Administered to All Patients With Programmed Death-Ligand 1 Expressing Surgically Resected Stage II to III NSCLC After Chemotherapy: In FavorMelina E Marmarelis, Lova Sun, Charu Aggarwal
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2025
Management of Patients With <i>EGFR</i> Exon 20-Mutant Advanced Non-Small Cell Lung CancerLova Sun, Melina E Marmarelis, Charu Aggarwal
Seminars in Radiation Oncology|February 21, 2021
Systemic Therapy for Mutation-Driven NSCLCLova Sun, Melina E Marmarelis, Corey J Langer
Plos One|February 19, 2013
Activity of the heat shock protein 90 inhibitor ganetespib in melanomaXinqi Wu, Melina E Marmarelis, F Stephen Hodi
Plos One|August 29, 2024
Correction: Activity of the Heat Shock Protein 90 Inhibitor Ganetespib in MelanomaXinqi Wu, Melina E Marmarelis, F Stephen Hodi
Clinical Lung Cancer|March 19, 2023
Chemoimmunotherapy vs. Immunotherapy for First Line Treatment of Advanced Non-small Cell Lung Cancer With a PD-L1 Expression ≥50% or ≥90Mohsin Shah, Ronac Mamtani, Melina E Marmarelis, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Current Oncology Reports|May 10, 2018
Combination Immunotherapy in Non-small Cell Lung CancerMelina E Marmarelis, Charu Aggarwal
JAMA Network Open|June 30, 2025
Immunotherapy for Resectable Non-Small Cell Lung Cancer-Not If, But WhenLauren Reed-Guy, Melina E Marmarelis
Clinical Lung Cancer|June 8, 2020
Treatment of Patients With Non-Small-Cell Lung Cancer Harboring Rare Oncogenic MutationsMelina E Marmarelis, Corey J Langer
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2020
Next-generation Sequencing of Cerebrospinal Fluid: How Can a Liquid be Like a Solid?Melina E Marmarelis, Joshua M Bauml
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 26, 2023
Adjuvant Atezolizumab Should Be Administered to All Patients With Programmed Death-Ligand 1 Expressing Surgically Resected Stage II to III NSCLC After Chemotherapy: In FavorMelina E Marmarelis, Lova Sun, Charu Aggarwal
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2025
Management of Patients With <i>EGFR</i> Exon 20-Mutant Advanced Non-Small Cell Lung CancerLova Sun, Melina E Marmarelis, Charu Aggarwal
Seminars in Radiation Oncology|February 21, 2021
Systemic Therapy for Mutation-Driven NSCLCLova Sun, Melina E Marmarelis, Corey J Langer
Plos One|February 19, 2013
Activity of the heat shock protein 90 inhibitor ganetespib in melanomaXinqi Wu, Melina E Marmarelis, F Stephen Hodi
Plos One|August 29, 2024
Correction: Activity of the Heat Shock Protein 90 Inhibitor Ganetespib in MelanomaXinqi Wu, Melina E Marmarelis, F Stephen Hodi
Clinical Lung Cancer|March 19, 2023
Chemoimmunotherapy vs. Immunotherapy for First Line Treatment of Advanced Non-small Cell Lung Cancer With a PD-L1 Expression ≥50% or ≥90Mohsin Shah, Ronac Mamtani, Melina E Marmarelis, et al.
Pageof 7